Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report
Erythrodermic psoriasis (EP) is a rare and severe form of psoriasis that affects 1 to 2.25% of patients, increasing mortality risk. To date, very few therapies have been approved for the treatment of this condition. Recently, biological therapies which specifically target inflammatory cytokines have...
Saved in:
| 主要作者: | |
|---|---|
| 格式: | 图书 |
| 出版: |
AboutScience Srl,
2022-03-01T00:00:00Z.
|
| 主题: | |
| 在线阅读: | Connect to this object online. |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
因特网
Connect to this object online.3rd Floor Main Library
| 索引号: |
A1234.567 |
|---|---|
| 复印件 1 | 可用 |